Energy saving potential and strategies for electric lighting in future North European, low energy office buildings: A literature reviewDUBOIS, Marie-Claude; BLOMSTERBERG, Ake.Energy and buildings. 2011, Vol 43, Num 10, pp 2572-2582, issn 0378-7788, 11 p.Article

Effects of glazing colour type on perception of daylight quality, arousal, and switch-on patterns of electric light in office roomsARSENAULT, Helene; HEBERT, Marc; DUBOIS, Marie-Claude et al.Building and environment. 2012, Vol 56, pp 223-231, issn 0360-1323, 9 p.Article

Tools and methods used by architects for solar designKANTERS, Jouri; HORVAT, Miljana; DUBOIS, Marie-Claude et al.Energy and buildings. 2014, Vol 68, pp 721-731, issn 0378-7788, 11 p., cArticle

L'association nationale pour la formation permanente du personnel hospitalier (ANFH). DossierGILIBERT, Pierre; MICHEL, Alain; DUBOIS, Marie-Claude et al.CAHIERS HOSPITALIERS (LES). 2010, Num 272, pp 5-11, issn 0295-4591, 7 p.Article

Recombinant Liver Stage Antigen-1 (LSA-1 ) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infectionCUMMINGS, James F; SPRING, Michele D; LANAR, David E et al.Vaccine. 2010, Vol 28, Num 31, pp 5135-5144, issn 0264-410X, 10 p.Article

Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine aloneSTEWART, V. Ann; MCGRATH, Shannon M; DEMOITIE, Marie-Ange et al.Infection and immunity. 2007, Vol 75, Num 5, pp 2283-2290, issn 0019-9567, 8 p.Article

Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. CommentaryALONSO, Pedro L; SACARLAL, Jahit; BASSAT, Quique et al.Lancet (British edition). 2004, Vol 364, Num 9443, pp 1380-1383, issn 0140-6736, 14 p.Article

Long-Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican ChildrenSACARLAL, Jahit; AIDE, Pedro; VEKEMANS, Johan et al.The Journal of infectious diseases. 2009, Vol 200, Num 3, pp 329-336, issn 0022-1899, 8 p.Article

Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of ProtectionKESTER, Kent E; CUMMINGS, James F; JUOMPAN, Laure et al.The Journal of infectious diseases. 2009, Vol 200, Num 3, pp 337-346, issn 0022-1899, 10 p.Article

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique : a double blind randomised controlled phase I/IIb trial. CommentaryEPSTEIN, Judith E; APONTE, John J; LEACH, Amanda et al.Lancet (British edition). 2007, Vol 370, Num 9598, issn 0140-6736, 1523-1524, 1543-1551 [11 p.]Article

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria : progress at the Walter Reed army institute of researchGRAY HEPPNER, D; KESTER, Kent E; MORIS, Philippe et al.Vaccine. 2005, Vol 23, Num 17-18, pp 2243-2250, issn 0264-410X, 8 p.Conference Paper

A Field Trial to Assess a Blood-Stage Malaria VaccineTHERA, Mahamadou A; DOUMBO, Ogobara K; DIALLO, Dapa A et al.The New England journal of medicine. 2011, Vol 365, Num 11, pp 1004-1013, issn 0028-4793, 10 p.Article

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01_E Malaria Candidate Vaccine When Integrated in the Expanded Program of ImmunizationAGNANDJI, Selidji T; ASANTE, Kwaku Poku; CHIKAWE, Maria et al.The Journal of infectious diseases. 2010, Vol 202, Num 7, pp 1076-1087, issn 0022-1899, 12 p.Article

Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of AgeBEJON, Philip; LUSINGU, John; DEMOITIE, Marie-Ange et al.The New England journal of medicine. 2008, Vol 359, Num 24, pp 2521-2532, issn 0028-4793, 12 p.Article

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adultsKESTER, Kent E; MCKINNEY, Denise A; KRZYCH, Urszula et al.Vaccine. 2007, Vol 25, Num 29, pp 5359-5366, issn 0264-410X, 8 p.Article

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialOLOTU, Ally; LUSINGU, John; VANSADIA, Preeti et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 2, pp 102-109, issn 1473-3099, 8 p.Article

Four year immunogenicity of the RTS,S/AS02_A malaria vaccine in Mozambican children during a phase IIb trialAIDE, Pedro; DOBANO, Carlota; HERREROS, Esperanza et al.Vaccine. 2011, Vol 29, Num 35, pp 6059-6067, issn 0264-410X, 9 p.Article

Safety and efficacy of the RTS,S/AS01_E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKWAKU POKU ASANTE; ABDULLA, Salim; SALIM, Nahya et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 741-749, issn 1473-3099, 9 p.Article

Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-γ and antibody responses in miceSHOTT, Joseph P; MCGRATH, Shannon M; DUBOIS, Patrice et al.Vaccine. 2008, Vol 26, Num 23, pp 2818-2823, issn 0264-410X, 6 p.Article

Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trialSACARLAL, Jahit; APONTE, John J; OFORI-ANYINAM, Opokua et al.Vaccine. 2008, Vol 26, Num 2, pp 174-184, issn 0264-410X, 11 p.Article

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in InfantsABDULLA, Salim; OBERHOLZER, Rolf; SALIM, Nahya et al.The New England journal of medicine. 2008, Vol 359, Num 24, pp 2533-2544, issn 0028-4793, 12 p.Article

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of ResearchPOLHEMUS, Mark E; MAGILL, Alan J; ROBINSON, Sally A et al.Vaccine. 2007, Vol 25, Num 21, pp 4203-4212, issn 0264-410X, 10 p.Article

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children : single-blind extended follow-up of a randomised controlled trialALONSO, Pedro L; SACARLAL, Jahit; GUINOVART, Caterina et al.Lancet (British edition). 2005, Vol 366, Num 9502, pp 2012-2018, issn 0140-6736, 7 p.Article